| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633437A Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/29/2005 | CN1633433A N-aroyl cyclic amines |
| 06/29/2005 | CN1633431A 喹唑啉衍生物类激酶抑制剂 Quinazoline derivatives kinase inhibitors |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633301A Extracts from sophora, production method and purposes thereof |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633291A 2-oxazolamines and their use as 5-ht2b receptor antagonists |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1633288A Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| 06/29/2005 | CN1633287A Biphenil derivatives and their use as antiandrogenic agents |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1633283A Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| 06/29/2005 | CN1631433A Capsule for treating prostate disease and its preparing process |
| 06/29/2005 | CN1631432A Chinese medicinal formulation for treating chronic renal insufficiency |
| 06/29/2005 | CN1631417A Chinese medicinal formulation for treating enuresis and urinary incontinence |
| 06/29/2005 | CN1631406A Tablet formulation of 'Jingui Shenqi', its preparation and derivative formulation |
| 06/29/2005 | CN1631388A Chinese traditional medicine for treating chronic prostatitis |
| 06/29/2005 | CN1208335C Thiazolidinedione derivative and its use as antidiabetic |
| 06/29/2005 | CN1208083C Chinese traditional medicine composition curing viscera inflammation, toxin and endocrine disorder |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911479 Side effect reduction; purity; removal of stereoisomers |
| 06/28/2005 | US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911217 Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005056561A1 Microcrystal and medicinal preparation containing the same |
| 06/23/2005 | WO2005056044A1 Use of c-reactive protein to treat immune complex-mediated renal disease |
| 06/23/2005 | WO2005055999A1 Anticholinergic agent |
| 06/23/2005 | WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 06/23/2005 | WO2002068380A8 Synthetic excitatory amino acids |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137229 Novel compounds |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050136502 Treatment of disorders associated with elevated blood glucose or blood pressure |
| 06/23/2005 | US20050136162 Enzymatic treatment with intermittent wet milling; heat treating; centrifugation and ultrafiltration separation; high value protein, fat, sugar, fiber and phytate fractions of distinct properties; low cost |
| 06/23/2005 | US20050136140 Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
| 06/23/2005 | CA2550136A1 Microcrystal and medicinal preparation containing the same |
| 06/23/2005 | CA2548922A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders |
| 06/23/2005 | CA2548276A1 Keto lactam compounds and use thereof |
| 06/23/2005 | CA2547784A1 Methods for treating prostatic intraepithelial neoplasia with herbal compositions |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543009A1 Pyrrolotriazine kinase inhibitors |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1542698A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542677A1 COMBINATIONS OF ATORVASTATIN AND a1, ADRENERGIC RECEPTOR ANTA GONISTS |
| 06/22/2005 | EP1542666A1 Modafinil pharmaceutical compositions |
| 06/22/2005 | EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1320523B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1244693B1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1100542B1 Peg-urate oxidase conjugates and use thereof |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630649A Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid |
| 06/22/2005 | CN1630645A 5-HT receptor ligands and uses thereof |
| 06/22/2005 | CN1630636A Indoline derivatives and their use as 5-HT2 receptor ligands |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630535A Inhibition of STAT-1 |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1628831A Freeze dried powder injection of dandehon herb and its preparation process |
| 06/22/2005 | CN1628827A Pharmaceutical composition for treating lumbago due to kidney-asthenia and its preparing process |
| 06/22/2005 | CN1628816A Process for preparing diabetes, piles and nephritis treating formulation |
| 06/22/2005 | CN1628814A Method for preparing 'Sanjin tablet' |
| 06/22/2005 | CN1628799A Clove leaf extract containing soft capsule and its preparation process |
| 06/22/2005 | CN1628788A Capsule for treating chronic prostatitis |
| 06/22/2005 | CN1628764A Creat formulation and its preparation process |
| 06/22/2005 | CN1628736A Injection free and drug administering free method for treating enuresis |
| 06/22/2005 | CN1628714A Method for preparing oral liquor to treat prostate inflammation |
| 06/22/2005 | CN1628687A Medicine composition for treating prostatitis |
| 06/22/2005 | CN1628646A Dispersed tablet of tartaric acid tolterodine tartrate |
| 06/22/2005 | CN1207268C Novel derivatives of 3-3-diphenylpropylamines |
| 06/22/2005 | CN1207054C Chinese medicine for treating nephropyelits |